A detailed history of 1620 Investment Advisors, Inc. transactions in Insulet Corp stock. As of the latest transaction made, 1620 Investment Advisors, Inc. holds 226 shares of PODD stock, worth $60,210. This represents 0.04% of its overall portfolio holdings.

Number of Shares
226
Previous 258 12.4%
Holding current value
$60,210
Previous $52,000 -0.0%
% of portfolio
0.04%
Previous 0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

SELL
$180.69 - $239.01 $5,782 - $7,648
-32 Reduced 12.4%
226 $52,000
Q2 2024

Jul 23, 2024

BUY
$161.02 - $206.98 $41,543 - $53,400
258 New
258 $52,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.5B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track 1620 Investment Advisors, Inc. Portfolio

Follow 1620 Investment Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1620 Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on 1620 Investment Advisors, Inc. with notifications on news.